Literature DB >> 14984470

Novel mutations in the CHST6 gene causing macular corneal dystrophy.

C Abbruzzese1, U Kuhn, F Molina, P Rama, M De Luca.   

Abstract

Macular corneal dystrophy (MCD) is an autosomal recessive disease characterized by corneal opacities and caused by mutations in a carbohydrate sulfotransferase gene, known as CHST6. MCD type I patients show missense mutations in the CHST6-coding region, and MCD type II patients show a large deletion and replacement in the upstream region of CHST6. The objective of this study was to identify the genetic defect in CHST6 gene causing MCD in Italian families. We investigated MCD genotype by using polymerase chain reaction followed by direct sequencing, and results were confirmed by restriction analysis. An enzyme-linked immunosorbent assay was performed to assess the presence of sulfated keratan sulfate in the serum of MCD patients. Biochemical analysis revealed a MCD type I phenotype in two families and a type II phenotype in another family. Two novel missense mutations and a polymorphism in the coding region of CHST6 gene were identified in patients with MCD type I. In one MCD II family, a homozygous deletion in the upstream region of CHST6 gene was found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984470     DOI: 10.1111/j.0009-9163.2004.00191.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

Review 1.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

2.  Macular corneal dystrophy: mutational spectrum in German patients, novel mutations and therapeutic options.

Authors:  Claudia Gruenauer-Kloevekorn; Saskia Braeutigam; Wolfram Heinritz; Ursula G Froster; Gernot I W Duncker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-24       Impact factor: 3.117

Review 3.  The IC3D classification of the corneal dystrophies.

Authors:  Jayne S Weiss; H U Møller; Walter Lisch; Shigeru Kinoshita; Anthony J Aldave; Michael W Belin; Tero Kivelä; Massimo Busin; Francis L Munier; Berthold Seitz; John Sutphin; Cecilie Bredrup; Mark J Mannis; Christopher J Rapuano; Gabriel Van Rij; Eung Kweon Kim; Gordon K Klintworth
Journal:  Cornea       Date:  2008-12       Impact factor: 2.651

4.  A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Authors:  Jing Zhang; Dan Wu; Yue Li; Yidan Fan; Yiqin Dai; Jianjiang Xu
Journal:  Aging (Albany NY)       Date:  2019-02-04       Impact factor: 5.682

5.  Matrix morphogenesis in cornea is mediated by the modification of keratan sulfate by GlcNAc 6-O-sulfotransferase.

Authors:  Yasutaka Hayashida; Tomoya O Akama; Nicola Beecher; Philip Lewis; Robert D Young; Keith M Meek; Briedgeen Kerr; Clare E Hughes; Bruce Caterson; Akira Tanigami; Jun Nakayama; Michiko N Fukada; Yasuo Tano; Kohji Nishida; Andrew J Quantock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-25       Impact factor: 11.205

6.  Macular corneal dystrophy in a Chinese family related with novel mutations of CHST6.

Authors:  Xiuhong Dang; Qingguo Zhu; Li Wang; Hong Su; Hui Lin; Nan Zhou; Ting Liang; Zheng Wang; Shangzhi Huang; Qiushi Ren; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-06       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.